ArticleCell discovery2021

Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo.

Zhaoyong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.